Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Clinical trial NCT01295060 · TERMINATED
Trial details
- NCT number
- NCT01295060
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-04-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.